Quick Heal Technologies Ltd. · NSE:QUICKHEAL

Quick Heal Technologies — Q2 FY18 Earnings Presentation

18 slides from Quick Heal Technologies's earnings presentation, November 2017

  1. Slide 1: Q2 & FY18 – Results Update

    Quick Heal Technologies Limited Q2 & FY18 – Results Update November 2017 1

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation and the following discussion may contain “forward looking statements” by Quick Heal Technologies Limited (“Quick Heal” or the “Company”) that are not historical in nature. These forward looking statements, which may include statements relating to future results of operat

  3. Slide 3: Large and Growing User Base – Annual Growth Trend

    LARGE AND GROWING USER BASE ACTIVE LICENSES (‘000) – ANNUAL GROWTH TREND 7,847 7,323 6,317 5,450 4,386 MAR-13 MAR-14 MAR-15 MAR-16 MAR-17 3

  4. Slide 4: Large and Growing User Base – Quarterly Growth Trend

    LARGE AND GROWING USER BASE ACTIVE LICENSES (‘000) – QUARTERLY GROWTH TREND 8,108 8,024 7,847 7,642 7,496 SEP-16 DEC-16 MAR-17 JUN-17 SEP-17 4

  5. Slide 5: Q2 & H1 FY18 Results Highlights

    Q2 & H1 FY18 RESULTS HIGHLIGHTS In Rs. Million Q2 FY18 YoY ANALYSIS REVENUES @ EBITDA and EBITDA MARGIN PAT and PAT MARGIN CASH PROFIT * 57% 37% 423 452 1,068 1,051 50% 32% 538 595 346 385 2% 7% Q2 FY17 Q2 FY18 Q2 FY17 Q2 FY18 Q2 FY17 Q2 FY18 Q2 FY17 Q2 FY18 EBIDTA EBIDTA Margin % PAT PAT Margin % C

  6. Slide 6: Q2 & H1 FY18 – Revenue Analysis

    Q2 & H1 FY18 – REVENUE ANALYSIS In Rs. Million Q2 FY18 YoY ANALYSIS H1 FY18 YoY ANALYSIS SEGMENT BREAKUP * SEGMENT BREAKUP * 1,187 1,149 1,699 129 165 1,463 269 309 15 % 27 % 1,058 985 1,431 1,154 19 % 7% Q2 FY17 Q2 FY18 H1 FY17 H1 FY18 % Share Q2 FY17 Q2 FY18 % Share H1 FY17 H1 FY18 Retail 89% 86%

  7. Slide 7: Q2 & H1 FY18 – License Selling Pattern

    Q2 & H1 FY18 – LICENSE SELLING PATTERN Q2 FY18 YoY ANALYSIS H1 FY18 YoY ANALYSIS NUMBER OF LICENSES SOLD * (‘000) NUMBER OF LICENSES SOLD * (‘000) 2,293 3,181 2,183 2,795 267 454 221 542 20 % 19 % 1,962 2,026 2,726 2,253 3% 17 % Q2 FY17 Q2 FY18 H1 FY17 H1 FY18 % Share Q2 FY17 Q2 FY18 % Share H1 FY17

  8. Slide 8: Q2 & H1 FY18 – Cost Analysis

    Q2 & H1 FY18 – COST ANALYSIS In Rs Million Consolidated Head Q2 FY18,a Q1 FY18,a Q4 FY17,a Q3 FY17, a Q2 FY17, a Operating Cost Salaries 113.8 116.8 116.5 118.7 122.4 Fees for technical services 20.7 24.1 24.9 24.9 25.2 Technology subscription charges 4.3 3.5 14.2 13.6 16.2 R&D Expenses (A) 138.8 14

  9. Slide 9: Q2 & H1 FY18 – Working Capital Analysis

    Q2 & H1 FY18 – WORKING CAPITAL ANALYSIS ADOPTION OF EFFICIENT SALES & CREDIT MECHANISM LEADING TO IMPROVEMENT IN WORKING CAPITAL CYCLE • Increased focus on timely stock clearance at dealers and receivables collection. • Increased handholding between sales team and dealer-retailer network to ensure f

  10. Slide 10: Q2 & H1 FY18 – Employee Breakup

    Q2 & H1 FY18 – EMPLOYEE BREAKUP September 2016 – 1,402 June 2017 – 1,318 September 2017 – 1,239 Sales & Marketing 210 208 199 382 R&D 390 379 262 269 245 Technical Support 451 416 548 Others 10

  11. Slide 11: Consolidated Results – Profit & Loss

    Q2 & H1 FY18 CONSOLIDATED RESULTS – PROFIT & LOSS In Rs Million Consolidated Head Q2 FY18,a Q2 FY17,a Growth % Change H1 FY18,a H1 FY17,a Growth % Change Revenue 1,050.6 1,067.9 -17.2 -1.6% 1,353.8 1,543.4 -189.6 -12.3% Direct Cost 50.9 87.3 36.4 41.7% 69.0 132.8 63.8 48.1% Gross profit 999.7 980.6

  12. Slide 12: Consolidated Results – Ratio Analysis

    Q2 & H1 FY18 CONSOLIDATED RESULTS – RATIO ANALYSIS Ratio Analysis Consolidated Head Q2 FY18,a Q2 FY17,a H1 FY18,a H1 FY17,a Expenses Direct Cost / Revenue 4.8% 8.2% 5.1% 8.6% R&D / Revenue 13.2% 15.3% 20.9% 20.9% S&M / Revenue 13.9% 15.4% 23.6% 21.6% G&A / Revenue 11.4% 10.7% 18.3% 16.3% Total Cost

  13. Slide 13: H1 FY18 Consolidated Results – Balance Sheet

    H1 FY18 CONSOLIDATED RESULTS – BALANCE SHEET Particulars (In Rs Mn) Sep-17 Sep-16 Particulars (In Rs Mn) Sep-17 Sep-16 Non-Current Assets: Share Holders’ Funds: Property, plant and equipment 1,716.8 1,721.0 Equity Share Capital 701.9 700.3 Capital work-in-progress 133.0 297.5 Other Intangible assets

  14. Slide 14: Standalone Results – Profit & Loss

    Q2 & H1 FY18 STANDALONE RESULTS – PROFIT & LOSS In Rs Million Standalone Head Q2 FY18, a Q2 FY17, a Growth % Change H1 FY18, a H1 FY17, a Growth % Change Revenue 1,045.3 1,064.3 -19.0 -1.8% 1,342.5 1,539.4 -196.9 -12.8% Direct Cost 50.2 82.1 31.9 38.8% 69.1 125.0 55.9 44.7% Gross profit 995.1 982.2

  15. Slide 15: Standalone Results – Ratio Analysis

    Q2 & H1 FY18 STANDALONE RESULTS – RATIO ANALYSIS Ratio Analysis Standalone Head Q2 FY18, a Q2 FY17, a H1 FY18, a H1 FY17, a Expenses Direct Cost / Revenue 4.8% 7.7% 5.1% 8.1% R&D / Revenue 13.3% 15.4% 21.1% 21.0% S&M / Revenue 13.3% 14.4% 22.8% 19.9% G&A / Revenue 11.0% 10.3% 17.8% 15.9% Total Cost

  16. Slide 16: H1 FY18 Standalone Results – Balance Sheet

    H1 FY18 STANDALONE RESULTS – BALANCE SHEET Particulars (In Rs Mn) Sep-17 Sep-16 Particulars (In Rs Mn) Sep-17 Sep-16 Non-Current Assets: Share Holders’ Funds: Property, plant and equipment 1,715.4 1,719.1 Equity Share Capital 701.9 700.3 Capital work-in-progress 133.0 297.1 Other Intangible assets 5

  17. Slide 17: Shareholding Structure

    SHAREHOLDING STRUCTURE Public, 19.75% Institutions, 7.55% % Shareholding – September 2017 Promoter & Promoter Group, 72.70% Source – BSE 17

  18. Slide 18: For Further Queries

    FOR FURTHER QUERIES Mr Rajesh Ghonasgi Vatsal Mehta / Nilesh Dalvi Quick Heal Technologies Limited Dickenson Seagull IR CFO IR Consultant Email ID: rajesh.ghonasgi@quickheal.co.in Email ID: vatsal.Mehta@dickensonsir.com Contact No: +91 (20) 6681 3232 nilesh.dalvi@dickensonir.com Contact No:+91 97121

Quick Heal Technologies — Q2 FY18 Earnings Presentation on 6ix